In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Dilated cardiomyopathy with midrange ejection fraction at diagnosis: characterization and natural history

Session Comorbidities and cardiomyopathies - How to manage?

Speaker Antonio Cannata

Event : Heart Failure 2018

  • Topic : valvular, myocardial, pericardial, pulmonary, congenital heart disease
  • Sub-topic : Dilative Cardiomyopathy
  • Session type : Rapid Fire Abstracts

Authors : P Gentile (Trieste,IT), M Merlo (Trieste,IT), A Cannata' (Trieste,IT), M Gobbo (Trieste,IT), M Mase (Trieste,IT), D Zaffalon (Trieste,IT), M Gigli (Trieste,IT), G Barbati (Trieste,IT), F Ramani (Trieste,IT), D Stolfo (Trieste,IT), B Pinamonti (Trieste,IT), G Sinagra (Trieste,IT)

Authors:
P Gentile1 , M Merlo1 , A Cannata'1 , M Gobbo1 , M Mase1 , D Zaffalon1 , M Gigli1 , G Barbati2 , F Ramani1 , D Stolfo1 , B Pinamonti1 , G Sinagra1 , 1Ospedale Cattinara, Cardiovascular Department - Trieste - Italy , 2University of Trieste, Biostatistics Unit, Department of Medical Sciences - Trieste - Italy ,

Citation:

Background. Few data on the characteristics and outcomes of mid-range EF (mrEF) patients are available, mostly in the specific group of dilated cardiomyopathy (DCM).

Purpose. To define characteristics, evolution and prognosis of DCM patients with mrEF at diagnosis.

Methods DCM patients were analyzed. mrEF and reduced EF (rEF) were defined in presence of baseline left ventricular EF between 40 and 49% and <40% respectively. The study end-points were all-cause mortality or heart transplantation (D/HT) and sudden cardiac death or malignant ventricular arrhythmias (SD/MVA). EF worsening below 40% during follow-up was also considered.

Results. Among 812 DCM enrolled patients, 175 (22%) presented mid-range EF at baseline. Compared with rEF group, mrEF patients had smaller left ventricular end-diastolic volume, lower rates of left bundle branch block, right ventricular dysfunction, moderate–severe mitral regurgitation and restrictive filling pattern. During a mean follow–up of 135±87 months, mrEF group presented a lower rate of D/HT (9.1% vs. 36%, p‹0.001) and SD/MVA (4.5% vs.15.2%, p‹0.001). Finally, 29 out of 175 mrEF patients (17%) evolved to rEF at a mean follow–up of 64±40 months, showing a subsequent worsening of long–term prognosis. A restrictive filling pattern emerged as the strongest predictor of rEF development at multivariate analysis. Conclusions.  mrEF identified a consistent subgroup of DCMs diagnosed in an earlier stage and presenting an apparent better long-term evolution. However, 17% of those patients evolved into rEF despite medical therapy. Baseline restrictive filling pattern was found to be independently associated with subsequent evolution in rEF.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are